During host cell invasion, the eukaryotic pathogen Toxoplasma gondii forms a 10 parsitophorous vacuole to safely reside within, while partitioned from host cell defense 11 mechanisms. From within this safe niche parasites sabotage multiple host cell systems 12 including gene expression, apoptosis and intracellular immune recognition by secreting a large 13 arsenal of effector proteins. Many parasite proteins studied for active host cell manipulative 14 interactions have been kinases. Translocation of effectors from the parasitophorous vacuole 15 into the host cell is mediated by a putative translocon complex, which includes proteins MYR1, 16 MYR2, and MYR3. Whether other proteins are involved in the structure or regulation of this 17 putative translocon is not known. We have discovered that the secreted protein GRA44, which 18 contains a putative acid phosphatase domain, interacts with members of this complex and is 19 required for host cell effects downstream of effector secretion. We have determined GRA44 is 20 processed in a region with homology to sequences targeted by protozoan proteases of the 21 secretory pathway and that both major cleavage fragments are secreted into the 22
parasitophorous vacuole. Immunoprecipitation experiments showed that GRA44 interacts with 23 a large number of secreted proteins included MYR1. Importantly, conditional knockdown of 24 GRA44 resulted in a lack of host cell cMyc upregulation, which mimics the phenotype seen 25 when members of the translocon complex are genetically disrupted. Thus, the putative acid 26 phosphatase GRA44 is crucial for host cell alterations during Toxoplasma infection and is 27 associated with the translocon complex which Toxoplasma relies upon for success as an 28 intracellular pathogen. 29
IMPORTANCE 30
Approximately one third of humans are infected with the parasite Toxoplasma gondii. 31
Toxoplasma infections can lead to severe disease in those with a compromised or suppressed 32 immune system. Additionally, infections during pregnancy present a significant health risk to 33 the developing fetus. Drugs that target this parasite are limited, have significant side effects, 34 and do not target all disease stages. Thus, a thorough understanding of how the parasite 35
propagates within a host is critical in the discovery of novel therapeutic targets. To replicate 36
Toxoplasma requires to enter the cells of the infected organism. In order to survive the 37 environment inside a cell, Toxoplasma secretes a large repertoire of proteins, which hijack a 38 number of important cellular functions. How these Toxoplasma proteins move from the 39 parasite into the host cell is not well understood. Our work shows that the putative 40 phosphatase GRA44 is part of a protein complex responsible for this process.
INTRODUCTION 42
Toxoplasma gondii is an obligate intracellular eukaryotic pathogen infecting an estimated 43 one-third of the human population globally. Approximately 15% of the US population is positive 44
for Toxoplasma infection (1) , while some countries in Europe and South America have much 45 higher infection rates. Within the human host, Toxoplasma exists as either highly-proliferative 46 tachyzoites, which are responsible for the acute stage of the infection, or latent bradyzoite 47 cysts, which form in various tissues and establish a chronic infection. While most infections are 48 asymptomatic, in immunocompromised individuals and lymphoma patients, new infections or 49 re-activation of pre-existing cysts can lead to toxoplasmic encephalitis, among other 50 complications (2-4). Additionally, a primary infection puts pregnant women at risk of passing 51 parasites to the developing fetus, which can cause miscarriage and severe birth defects (5) . 52
Due to its biological niche as an obligate intracellular parasite, Toxoplasma depends upon 53 remodeling the host cell environment to facilitate its own growth and survival. As the parasite 54 invades a host cell, it forms an insular vacuole, known as the parasitophorous vacuole (PV), 55 within which they safely replicate undisturbed by host cell innate immune machinery. Within 56 the PV, parasites interface with the host cell through the PV membrane while avoiding direct 57 contact with host cell components. Mediation of interactions between parasites and the host 58 cell is accomplished by a multitude of parasite proteins that are secreted during invasion from 59 the rhoptries (ROP proteins) and during intracellular growth from the dense granules (GRA 60 proteins). Many of these proteins are secreted beyond the PV into the host cell to directly 61 manipulate host processes like transcription, apoptosis, immune responses and metabolism 62 (6, 7). Additional proteins are secreted but retained within the PV for the purpose of trafficking 63 these effectors to the host cytoplasm. The proteins MYR1, MYR2 and MYR3, components of a putative translocon system, are secreted to the PV and are responsible for altering a wide 65 array of host processes by trafficking effectors to the host (8). Secreted proteins, especially 66 those with enzymatic activity such as kinases and phosphatases, are of great interest, as they 67 hold potential as drug targets due to their exclusivity to apicomplexans and importance to 68 parasite survival. Two kinases secreted during invasion and intracellular growth that are known 69 to be critical for host manipulation and parasite virulence are ROP16 (9) and ROP18 (10). The 70 ROP16 kinase acts to downregulate STAT3/6 in the host nucleus, which results in altered 71 transcription (11). ROP18, in partnership with GRA7, counteracts host cell immune responses 72 by phosphorylation and inactivation of host Immunity-Related GTPase (IRG) proteins, which 73 otherwise act to signal PV degradation (12). Other Toxoplasma kinases known to be secreted 74 into the host cell include WNG1 and WNG2, formerly ROP35 and ROP34 respectively (13). 75
Additionally, several pseudokinases have been shown to be secreted into the host and are 76 implicated in host-cell manipulation such as ROP5, which complexes with ROP18 conferring 77 binding affinity to host IRGA6 (12). 78
Whether secreted phosphatases play a similarly important role as do secreted kinases and 79 pseudokinases remains largely unexplored. The secreted phosphatase PP2C has been 80 proposed to reduce apoptosis of infected host cells (14) and the phosphatase PP2C-hn has 81 been found in the host nucleus (15) , although its function remains unclear. To expand our 82 understanding of phosphatases secreted to either the host or PV, we bioinformatically 83 identified 32 proteins predicted to have both a phosphatase domain and signal sequence. Of 84 those identified, we characterized the biological role of TGGT1_228170 which was previously 85 identified as part of the inner membrane complex and named IMC2A by Mann and Beckers 86 (16) . However, contrary to the initially documented localization, this protein contains characteristics of secreted proteins namely a signal sequence and predicted TEXEL motifs, 88 protease cleavage sites found in many Toxoplasma secreted proteins (17). Here we show that 89 this protein is both processed and secreted into the PV where it interacts with the proposed 90 translocation complex of MYR1/2/3. Importantly, we show that TGGT1_228170, now renamed 91 GRA44, is critical for activation of the host oncogenic factor cMYC. 92
RESULTS 94

Bioinformatic search for secreted phosphatase 95
To begin identifying putative secreted phosphatases, we used a bioinformatics approach 96 starting with all proteins annotated in the Toxoplasma gondii genome database ToxoDB 97 (toxodb.org). A blast search of all Toxoplasma genes, filtered by only including genes whose 98 products contain predicted phosphatase domains and signal peptides, generated a list 99 containing 32 proteins of potential interest (Table S1 in supplemental material). To prioritize 100 our studies on phosphatases that are likely to play an important role in parasite propagation, 101
we ranked our list according to gene fitness scores as assigned through a genome-wide 102 CRISPR/Cas9 knockout study (18) . Among these is TGGT1_228170, a protein that contains a 103 predicted acid phosphatase domain ( Fig. 1A ) and, that despite having a signal sequence, was 104 previously described as localizing to the inner membrane complex (IMC) (16). However, 105 multiple lines of evidence suggest that it may indeed be secreted. First, the homologous 106 protein UIS2 in the related apicomplexan parasite Plasmodium berghei has been shown to 107 have a secreted ortholog (Pf3D7_1464600) in Plasmodium falciparum (19) . Second, 108 TGGT1_228170 has been repeatedly detected in BioID experiments as an interactor of 109 proteins localized to the PV lumen and PV membrane microenvironments (20). Finally, 110 analysis of the protein sequence revealed multiple putative Toxoplasma Export Elements 111 (TEXEL), which at the time this investigation began was defined as RxLxD/E (21), and has 112 since been refined as RRL (22). TEXEL sequences are recognized by a Golgi-associated 113 protease, aspartyl protease V (ASP5), which cleaves proteins as part of the secretory pathway 114 to the PV/PVM and host cell. Based on these criteria and the fact TGGT1_228170 was assigned a gene knockout fitness score of -3.28, indicating that it substantially contributes to 116 parasite fitness, we decided to revisit the localization and function of this protein. 117
TGGT1_228170 is processed and secreted into the parasitophorous vacuole 118
To determine the localization of TGGT1_228170, we introduced sequences encoding three 119 C-terminal hemagglutinin epitope tags (3xHA) into the endogenous gene by homologous 120 recombination ( Fig. 1A) . Western blot analysis of protein extract from both intracellular and 121 extracellular parasites of the TGGT1_228170(HA) line showed a band of approximately 122 180kDa, which is the expected size for the full protein ( Fig. 1B ). However, a second prominent 123 band at approximately 40kDa was also noted in both intracellular and extracellular parasites 124 ( Fig. 1B ). This second smaller band is consistent with processing at either of two areas with 125 homology to TEXEL sites (Fig. 1A) . The sequence for the first of these putative cleavage sites 126 is RELEE (amino acids 1205-1209), which is consistent with previous TEXEL consensus, while 127 the sequence for the second is RRLLE (amino acids 1348-1352), which is consistent with the 128 RRL consensus sequencee ( Fig. 1A) . 129
To confirm the identity of the 40kDa fragment observed in western blot, endogenously 130 tagged TGGT1_228170 was immunoprecipitated and the eluate separated by SDS-PAGE. 131
Finally, to determine the localization of TGGT1_228170, we performed 139 immunofluorescence assays (IFA) of TGGT1_228170(HA) parasites. Consistent with the 140 presence of a signal sequence and putative TEXEL sites, TGGT1_228170 was detected within 141 the PV lumen and at the PV membrane (PVM; Fig. 1D ). Based on this localization and 142 corroborative findings by Coffey et al. on the same protein (13), TGGT1_228170 should be 143 designated as a GRA protein, and we will henceforth refer to it as GRA44. 144
Amino acids 1348-1352 are required for efficient processing of GRA44 145
We hypothesized that the small C-terminal fragment of GRA44 detected by Western blot 146 and M/S is the product of cleavage at either of the two putative TEXEL sequences. To 147 investigate which of the two sites is actively cleaved, we exogenously expressed GRA44 with 148 the first arginine of either or both of these sites mutated to alanine ( Fig. 2A ). The first arginine 149 of TEXEL sites has been previously shown to be important for cleavage (21). Western blot 150 analysis showed that mutating the first arginine of the first putative site (GRA44 R1205A) did 151 not affect processing of the protein (Fig. 2B ). By contrast, mutating the arginine in the second 152 site (GRA44 R1348A) significantly reduced processing (Fig. 2B ). The same result was 153 observed when both putative TEXEL sites were mutated (GRA44 R1205A/R1348A) ( Fig. 2B ). 154 Densitometry analysis showed that while for the wild type protein 82.9%±9.9 (n=3) of total 155 protein is cleaved, cleavage in the GRA44 R1348A is 47.4%±9.9 (n=3). Thus, it appears that 156 the second TEXEL is the site for processing of GRA44, and it is referred to as the GRA44 157 TEXEL from now on. For a thorough examination of the identified TEXEL, we generated 158 parasites exogenously expressing GRA44 in which either L1350 or E1352 are mutated for 159 alanine ( Fig. S1A in supplemental material). As was the case for the R1348A mutation, 160 changing the central leucine in the GRA44 TEXEL to an alanine disrupted processing (Fig. S1B in supplemental material), however mutant E1352A showed similar levels of processing 162 as the wildtype protein ( Fig. S1B in supplemental material). 163
Although we observed a significant reduction in cleavage after altering single amino acids 164 in the GRA44 TEXEL, there appeared to be some residual C-terminal cleavage product 165 present with all mutants ( Fig. 2B and S1B). To ascertain whether this was the effect of 166 persistent cleavage at TEXEL despite the mutations or cleavage at an alternative site, we 167 generated an exogenously expressed GRA44 mutant in which all five amino acids that make 168 up this TEXEL were deleted (∆1348-1352). As expected, deletion of the TEXEL resulted in 169 significant loss of the C-terminal cleavage product ( Fig. 2C ). However, it was evident there still 170 remained a measurable amount being cleaved. Cleavage level for ∆1348-1352 was calculated 171 at 21.1±7.7 (n=3), which is significantly lower than the point mutant R1348A (see above). 172
Since the TEXEL was not present in this mutant form of GRA44, it is plausible that a cryptic 173 site is used, potentially amino acids 1205-1209. Alternatively, GRA44 may be cleaved by a 174 TEXEL/ASP5 independent mechanism. 175
To determine whether effective processing is needed for localization of GRA44 to the PV, 176 we performed IFAs with parasites expressing each of the four mutant GRA44 (R1205A, 177 R1348A, R1205A/R1348A, and Δ1348-1352). Interestingly, none of the mutations affected 178 secretion and localization to the parasitophorous vacuole ( Fig. 2D ). Similarly, mutating L1350 179 or E1352 within the confirmed TEXEL site did not affect the PV localization of GRA44 ( Fig.  180 S1C in supplemental material). These results indicate that complete processing is not required 181 for protein secretion.
Both the N-terminal and C-terminal GRA44 cleavage products localize within the PV 183
As the localization analysis performed depended on a C-terminal HA epitope tag and 184 GRA44 is cleaved at an internal TEXEL site, we could only detect the full-length uncleaved 185 protein and smaller C-terminal fragment. Consequently, with the C-terminal HA tagged protein 186 we cannot determine the localization of N-terminal cleavage product, which contains the 187 putative acid phosphatase domain. Accordingly, we engineered a strain exogenously 188 expressing GRA44 containing a MYC epitope tag inserted between amino acids 1203 and 189 1204 in addition to the HA epitope tag at the C-terminus ( IFA. Regardless of whether we used HA or MYC antibodies, the protein was localized primarily 198 to the PV, which suggests that the two major fragments, including the one containing the 199 phosphatase domain, are secreted into the parasitophorous vacuole ( Fig. 3C ). 200
Loss of GRA44 negatively affects parasite propagation 201
Through a genome wide CRISPR screen, GRA44 was assigned a log2 relative fitness 202 score of -3.28 (18) , which would suggest that loss of GRA44 would be a significant detriment 203 to parasite propagation. Accordingly, we applied a tetracycline (tet) repressible system (23, 24) 204 to establish a conditional GRA44 knockdown strain. Specifically, we used CRISPR to introduce a cassette encoding a drug selective marker, a transactivator (TATi) protein and a tetracycline 206 response element (TRE) just upstream of the endogenous GRA44 start codon ( Fig. 4A ). As to 207 be able to monitor GRA44 protein expression we engineered the conditional knockdown 208 mutant using the GRA44(HA) strain. The resulting strain, TATi-GRA44(HA) was grown for 24 209 and 48 hours in the absence and presence of the tetracycline analog anhydrotetracycline 210 (ATc) and GRA44 expression was monitored by Western blot ( Interestingly, we noted the small C-terminal fragment from the TATi-GRA44(HA) strain was 215 smaller than what is observed with the parental endogenous HA strain ( Fig. 1B and 4B ). 216
Sequencing of GRA44 in the TATi-GRA44(HA) strain showed that a 315 base pair fragment, 217 which encodes the last 105 amino acids, was deleted leaving the HA tag in frame. Surprisingly, 218
we did not note any significant growth defect and successfully complemented with a full-length 219 gene construct ( Fig 4D, comparing parental to knockdown strain grown without ATc). Thus, 220 deletion of that region does not affect localization or function. Regardless, this strain allows us 221 to study the consequence of eliminating GRA44 expression upon ATc addition. In addition, to 222 ensure that any phenotype is due to downregulation of GRA44 we complemented this strain 223 with the addition of a wildtype copy of the gene (see below). Importantly, when the TATi-224 GRA44(HA) strain is grown in the presence of ATc, depleting GRA44, propagation is 225 significantly affected as compared to the growth by the same strain under normal conditions 226 ( Fig. 4D ). For the conditional knockdown strain, in the absence of ATc, we quantitated an 227 average cell clearance of 19.4±9.9%, which was reduced to 0.9±0.4% when ATc was included in the growth medium ( Fig. 4D ). Therefore, conditional knockdown of GRA44 significantly 229 reduces parasite propagation in tissue culture. 230
Processing is not necessary for GRA44 function 231
To confirm the propagation defect observed upon knockdown of GRA44 was due to the 232 reduction of GRA44 levels, we tested whether an exogenous copy of GRA44 could 233 complement the phenotype. For this purpose, we introduced a copy of GRA44 with a C-234 terminal MYC epitope tag into the TATi-GRA44(HA) strain to generate a complemented strain 235
TATi-GRA44(HA)comp, (Fig. 5A ). The exogenous copy of GRA44(MYC) is processed and 236 secreted as expected ( Fig. 5B and C). In absence of ATc, both the endogenous HA-tagged 237 GRA44 and the exogenous MYC-tagged GRA44 were detected in this strain by both Western 238 blot and IFA ( Fig. 5B and C). As expected, addition of ATc resulted in knockdown of 239 GRA44(HA) but not of the exogenous GRA44(MYC) ( Fig. 5B and C). Plaque assay of both the 240 knockdown (TATi-GRA44(HA)) and complemented (TATi-GRA44(HA)comp) strains with and 241 without ATc were performed in parallel to determine the ability of GRA44 to complement the 242 phenotype. Consistent with the previous result, addition of ATc to the TATi-GRA44(HA) strain 243 severely impaired plaque formation ( Fig. 5D ). Importantly, presence of a constitutively 244 expressed copy of GRA44 complements this phenotype (Fig. 5D ). While the percentage 245 clearance of host cell in the presence of ATc was 0.8±0.4% for the knockdown strain after five 246 days in culture, it was 26.6±3.7% for the complemented strain, which is statistically equal to 247 what is observed without ATc with either strain (Fig. 5D ). Complementation of the plaquing 248 phenotype by the addition of a wildtype copy confirms that GRA44 is critical for efficient 249 propagation of Toxoplasma.
Having established complementation of the growth phenotype, we set to determine 251 whether processing of GRA44 was needed for function. Accordingly, we complemented the 252 TATi-GRA44(HA) strain with an exogenous copy of GRA44(MYC) containing a TEXEL deletion 253 of residues 1348-1352 to obtain the strainGRA44compΔTXL. For the GRA44compΔTXL strain 254 under normal growth conditions without ATc, endogenous GRA44(HA) is detected by Western 255 blot at a similar size to TATi-GRA44 and TATi-GRA44comp strains, however the exogenous 256 MYC-tagged GRA44compΔTXL copy is seen as a mostly uncleaved form of the protein, in 257 contrast to the wild type complement which is processed ( Fig. 5E ). Remarkably, the 258 GRA44compΔTXL complemented parasite strain was no longer sensitive to the presence of 259 ATc (Fig. 5E ). These results indicate that complete cleavage of GRA44 is not necessary for 260 function. 261
GRA44 interacts with members of the effector translocation complex 262
Our results have thus far shown GRA44 to be of significant importance for successful 263 parasite propagation, however the specific function of this protein within the parasitophorous 264 vacuole is unclear. To shed light on its function we examined what proteins interact with 265 GRA44 by developing a comprehensive interactome. For this purpose, GRA44 protein was 266 immunoprecipitated from the GRA44(HA) tagged line and co-precipitating peptides analyzed 267 by mass spectrometry. After three replicate experiments and controls with non-specific beads, 268 the data were statistically analyzed by SAINT (Significant Analysis of Interactome) (25) 269 computational predictive analysis (supplemental data set 1). With a SAINT score of >0.8 used 270
as a cutoff, we obtained a list of 35 putative interactors, of which 8 are ribosomal and snRNP 271 proteins and likely to be non-specific (Table S2 in supplemental material). Significantly, of the are likely secreted proteins (Table 1) . Among these are eight known GRA proteins (GRA9, 16, 274 25, 33, 34, 45, 50, and 52), the parasitophorous vacuole membrane associated protein MAF1, 275 and MYR1 a known member of the effector translocation complex (26, 27) . 276
To confirm the interaction with MYR1, for which there are antibodies (26), we performed 277 co-immunoprecipitating assays. Purified lysate from GRA44(HA) parasites was precipitated on 278 mouse anti-HA beads, and eluates evaluated by Western for presence of GRA44 and MYR1. 279
For MYR1, which is also processed by ASP5 at a TEXEL site, we probed with antibodies for 280 either the C-terminal or N-terminal cleavage product. Immunoprecipitated GRA44 yielded a 281 significant amount of either MYR1 fragment as compared to control IgG bead eluate of the 282 same source (Fig. 6 ). Thus, GRA44 appears to interact with a member of the effector 283 translocation system. 284
GRA44 is required for cMYC induction 285
MYR1 was identified through a forward genetic screen to be required for translocation of 286 parasite effectors such as GRA16 and GRA24 and the ensuing upregulation of the host cell 287 oncogene cMYC (26). Given GRA44's interaction with MYR1, we tested whether it might be 288 involved in the same functions, specifically cMYC induction. For this purpose, TATi-289 GRA44(HA) parasites were grown for 24 hours either with or without ATc, released from host 290 cells and allowed to infect new cells. Those that came from the +ATc conditions were kept in 291 ATc, while those from the -ATc culture were kept without it. After 12 hours of growth, cultures 292 were fixed and an IFA for human cMYC was performed ( The rhoptries discharge proteins known as ROPs during invasion, while the dense granules 313 release their contents into the PV during intracellular growth. While some of these so called 314 GRA proteins remain within the PV space or associate with the PV membrane (PVM), many of 315 them are translocated across the PVM into the host where they affect numerous signaling 316 pathways. How these proteins move from the PV to the host is becoming clear with the 317 discovery of proteins that appear to form part of a putative translocon (24). The work presented 318 here shows that GRA44 (TGGT1_228170), previously known as IMC2A (16), interacts with 319 members of this complex and that it is essential for some of the host cell events downstream of 320 effector translocation. 321
Work from Coffey et al. identified GRA44 as a substrate of ASP5 through a comparative 322 proteomic approach (13). They showed that indeed GRA44 is processed and secreted into the 323 PV, which we have corroborated with the work presented here. Their analysis of GRA44 324 identified two cleavage sites, one at 83-85 and another at 1348-1350. Nonetheless, their studies did not determine whether all cleavage products were secreted or the function/role of 326 GRA44 within the PV. Here we report that the two major GRA44 products are secreted into the 327 PV. This is important as it is the first evidence that the fragment containing the putative acid 328 phosphatase is indeed in the PV. In our study, we show that the processing is not necessary 329 for either the secretion or function of GRA44. This is consistent with the fact that other 330 secreted proteins containing TEXEL motifs such as MYR1 and WNG1/2 can still be secreted in 331 absence of ASP5 activity (13). Fortuitously, through a spontaneous deletion in the knockdown 332 strain, we also determined that the last 105 amino acids of the protein are not needed for 333 function or localization. 334
Proteomic analysis of proteins co-immunoprecipitated with GRA44, reveal interaction 335 with known secreted proteins, including numerous GRAs. Among these interactors are GRA9, 336 part of the intravacuolar tubular network (30), GRA16 an effector altering host cell cycle 337 through p53 pathway (31), GRA25 a macrophage-dependent immune modulator (32), GRA33, 338 GRA34, GRA45, GRA50, GRA52 and members of the multi-copy Mitochondrion Association 339 Factor 1 (MAF1) family. MAF1 is involved in recruiting the host mitochondria to the PV 340 membrane surface (33). Most importantly, immunoprecipitation revealed an interaction 341 between MYR1 and GRA44, which we have confirmed independently by Western blotting (Fig.  342   6) . Interestingly, as we were studying the interactome of GRA44 we learned of ongoing work in 343
Dr. Boothroyd's lab showing a physical and functional interaction between MYR1 and GRA44 344 (see accompanying manuscript). MYR1 was initially identified through a forward genetic 345 screen for Toxoplasma mutants unable to activate host cMYC and translocate effectors such 346 as GRA16 and GRA24 ( 22). Further screening for such mutants identified MYR2 and MYR3 347 as also required for effector translocation (27) . Thus, MYR1/2/3 appear to be part of a putative translocon complex, although only MYR1 and MYR3 have been confirmed to directly interact 349 (27) these findings support the notion that GRA44 is a member of the MYR1/2/3 translocon 360 machinery. Whether its role in this process is structural or regulatory remains unknown and 361 would require further investigation. The possibility that GRA44 plays a regulatory function is 362 suggested by the presence of a putative catalytic site reminiscent of acid phosphatases. 363
Whether GRA44 is an active phosphatase or a pseudophosphatase remains to be determined. 364
In the biology of animals, plants and fungi, acid phosphatases serve many biological 365 purposes and proteins are designated as such based on a shared similarity in catalytic site 366 structural arrangement (34). Typically these enzymes coordinate an Fe(III) and divalent metal 367 such as Mn(II), Zn(II) or Fe(II) as part of their active site. Each metal is coordinated to three 368 amino acids and shares a linking aspartic acid bridge between them with the Fe(III) typically 369 mated to a histidine, an asparagine and a tyrosine and the divalent metal bound by two 370 histidines and an asparagine. GRA44 contains a majority of the conserved residues common to acid phosphatases. In GRA44 the aspartic acid conjugating the Fe(III) is switched to an 372 asparagine and the asparagine conjugating the second metal is replaced by a glutamic acid. dephosphorylation of effectors for trafficking across the PVM structure. Typically, proteins must 386 be dephosphorylated to cross a lipid bilayer membrane such as the PVM and notably both 387 GRA16 and GRA24 have been shown to be phosphorylated as identified by Toxoplasma 388 phosphoproteome analysis (39)). MYR3 also exists in a partial phosphorylated state and could 389 be a substrate for a phosphatase such as GRA44 (27) . Consistent with the idea of 390 phosphoregulation of the export system, the secreted kinase ROP17 has been shown to be 391 critical for efficient effector translocation (40). 392 complete GRA44 knockout (13) and with the fitness score of -3.28 assigned to GRA44 through 395 a genome wide CRISPR screen (18) . This is particularly interesting, as disruption of other 396 translocon members do not affect fitness to the level seen with GRA44. For example, the 397 relative fitness scores for MYR1, MYR2, MYR3 are 0.88, 2.39 and 2.83 respectively, although 398 disruption of any of these interferes with effector translocation and cMYC activation. Similarly, 399 disruption of the effectors GRA16, GRA24 and TgIST, which depend on MYR1 for 400 translocation, have positive fitness scores of 1.44, 2.28 and 2.86. Thus, it is unlikely that the 401 growth defect exhibited by parasites lacking GRA44 is due to defects on effector translocation. 402
Alternatively, GRA44 might play several independent roles, including nutrient acquisition, 403 which would be consistent with known functions of acid phosphatases. 404
In conclusion, we have shown GRA44 to be a secreted protein critical for Toxoplasma 405 survival and propagation that plays a significant role in host manipulation and interacts with the 406 translocon protein MYR1. As part of its secretion to the PV it is cleaved at an internal TEXEL 407 site forming two stable and colocalizing proteins. The mechanistic action by which GRA44 is 408 involved with protein secretion to host cells remains unknown, however due to its putative acid 409 phosphatase domain, involvement with dephosphorylation of trafficked proteins or members of 410 the translocon complex is plausible. Future work on the activity and substrates of GRA44 will 411 shed light on the regulation of effector translocation, a process central to the interactions 412 between Toxoplasma and its host. 413
MATERIALS AND METHODS 415
Parasite and Host Cell Culture 
Development of GRA44 conditional knockdown parasite line 453
To generate the GRA44 conditional knockout strain we introduced a cassette encoding a 454 drug selective marker, a transactivator (TATi) protein and a tet response element (TRE) just 455 upstream of the GRA44 start codon. This TATi cassette was amplified from the vector 456 pT8TATi-Gra44-HX-tetO7S (46) with primers that include areas of homology upstream of 457 GRA44 to facilitate homologous recombination. 1μg of this PCR amplicon was transfected into 458 the RhΔKu80 parasites that express endogenously HA tagged GRA44. To drive the insertion 459 of the TATi cassette we co-transfected the PCR amplicon with 2μg of a vector expressing Cas9 and a guide RNA targeting the TGGT1_228170 locus upstream of the start codon. This 461 vector was made using pSAG1-Cas9-GFP-pU6-sgUPRT (47) as a template and the 462 sequences encoding the guide RNA were introduced with Q5 site directed mutagenesis (NEB). 463
Parasites transfected with the TATi cassette and Cas9 vector were selected for HPT and 464 independent clones established by limiting dilution. Correct integration of the TATi insert 465 cassette was validated by PCR. Resulting strain was designated TATi-GRA44(HA). 466
Complementation of conditional knockdown line 467
To complement the knockdown strain, a wildtype copy of TGGT1_228170 driven by a 468
Toxoplasma tubulin promoter and including a C-terminal MYC epitope tag was targeted to the 469 inactive Ku80 locus of theTATi-GRA44(HA) strain using CRISPR/Cas9 to assist integration. 470
The insertional cassette, which includes the tubulin-driven TGGT1_228170 and a 471 chloramphenicol resistance gene (48) was amplified by PCR from plasmid pTub-Gra44-myc-472
CmR with primers that included homology segments to the Ku80 locus (table S3 ).The pTub-473
Gra44-myc-CmR vector was constructed with Infusion assisted LIC cloning by inserting the 474 Gra44 gene with appended C-terminal myc tag, amplified from pTub-Gra44-HPT, to the pLIC-475 SMGFP-CmR vector backbone (49) replacing the SMGFP tag and upstream region. 1µg of this 476 PCR amplicon was co-transfected with 2 µg of Cas9 vector encoding an sgRNA targeting the 477 Ku80 locus. 478
SDS-PAGE and Western blot analysis 479
For detection of protein in lysates from extracellular parasite samples, parasites were 480 allowed to undergo natural egress then collected, centrifuged and washed 2x with cold PBS 481 (10 min, 1,000 x g). For analysis of intracellular parasite protein lysates, host cell monolayers samples were resuspended in 2X sample loading buffer with 5% β-mercaptoethanol and boiled 484 for 5 minutes at 98°C. Boiled samples were frozen at -20°C, then thawed and re-boiled for 5 485 minutes at 98°C before gel loading. SDS-PAGE and Western blots were performed with 486 standard methods as previously described (50). 487
For Western blot analysis of GRA44 conditional mutant strains, parasites were first grown 488 under normal conditions for 24 hours, then syringe lysed with a 27-gauge needle. Fresh host 489 cells were infected with an equal quantity of syringe lysed parasites and grown for 24 or 48 490 hours with or without 1μg/mL ATc. For analysis of protein lysates from extracellular parasite 491 samples, host cells were scraped and parasites released by passing through a syringe and 492 centrifuged 10 minutes at 1,000 x g. For analysis of intracellular parasite protein lysates, host 493 cell monolayers were washed with cold PBS, scraped and centrifuged for 10 minutes at 1,000 494
x g. Resulting samples were resuspended in 200 μL RIPA lysis buffer (50mM Tris, 150 mM 495 NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% TritonX-100) including 496 protease/phosphatase inhibitor cocktail (Cell Signaling Technology) and incubated on ice 1 497 hour, sonicated 2 times for 15 seconds with 1 minute rests on ice and centrifuged (20,000 x g, 498 15 minutes, 4°C). Supernatants were combined with 4X SDS loading buffer with 10% β-499 mercaptoethanol and boiled for 5 minutes at 98°C. Boiled SDS samples were frozen at -20°C, 500 then thawed and re-boiled for 5 minutes at 98°C before gel loading. SDS-PAGE and Western 501 blots were performed with standard methods as described above. Uncropped original images 502 for all western blots are included as a supplemental data set 2. 503 antibodies at 1:1,000 (26, 27) . Secondary antibodies used include peroxidase-conjugated goat 507 anti-mouse and anti-rabbit and were used at a 1:10,000 dilution. 508
Immunofluorescence assays 509
For all immunofluorescence assays (IFA), HFFs were grown to confluency on 1.5mm glass 510 coverslips and infected with parasites, which were allowed to grow for 20 hours prior to fixation 511 with 4% paraformaldehyde for 20 minutes. Cells were washed 1x with PBS after fixation, then 512 permeabilized and blocked with a solution of 3%BSA/0.2%Triton-X100 in PBS for 15-20 513 minutes. Coverslips were incubated with primary antibodies in 3%BSA/0.2%Triton-X100 in 514 PBS for one hour at room temperature and washed five times with PBS. Finally, cultures were 515 incubated with fluorophore-conjugated secondary antibodies for one hour at room temperature 516 in 3%BSA in PBS, then washed five times with PBS and mounted on glass slides with 517 vectashield mounting medium containing DAPI (Vector Laboratories). Primary antibodies used 518 were rabbit anti-HA at 1:1000, mouse anti-MYC at 1:1000 (Cell signaling Technology), rat anti-519 HA at 1:2000 (Roche), rabbit anti-human C-myc at 1:1000 (Abcam), mouse anti-gra5 (Biotem) 520 at 1:1000, and mouse anti-gra7 at 1:1000. Secondary antibodies used (Life Technologies) 521
were Alexafluor-488 goat anti-rabbit or goat anti-rat, alexafluor-594 goat anti-mouse or Goat 522 anti-Rabbit and Alexafluor-647 Goat anti-Mouse. All secondary antibodies were used at 523 1:2000. Images were taken on a Nikon Eclipse 80i microscope using a Nikon DS-Qi1Mc 524 camera and NIS Elements AR 3.0 software. 525
Immunoprecipitation and Co-IP experiments 526
Infected host cells were washed 2x with cold PBS and scraped from the flask surface to 527 collect intracellular parasites, which were centrifuged 10 minutes at 1,000 x g and 528 resuspended in 200 μL ice cold IP lysis buffer (Pierce, Thermo Scientific) containing protease and phosphatase inhibitors (Cell Signaling Technology). Lysate was incubated on ice one 530 hour, sonicated on ice 2x for 15 seconds and centrifuged 15 minutes at 20,000 x g and 4°C. 531
Supernatant was collected and incubated with magnetic beads conjugated to either mouse IgG 532 or primary antibody (Pierce, Thermo Scientific) for one hour at 4°C with rocking. Incubated 533 beads were separated from solution with a magnet and washed with IP lysis buffer (Pierce, 534 Thermo) plus inhibitors three times and either stored in 8M Urea at -80°C for downstream 535 mass spectrometric analysis or directly eluted into 2x SDS sample loading buffer/5% β-536 mercaptoethanol, boiled 5 minutes at 98°C, and stored at -20°C for Western blot analysis. 537 SDS-PAGE and Western blots were performed as outlined above. Protein analysis by mass 538 spectrometry was completed by Indiana University School of Medicine Proteomics Core facility 539 as previously described (50). 540
Plaque assays 541 12-well plates were infected with 500 parasites/well of freshly syringe-lysed parasites and 542 grown undisturbed for 5 days before fixation with methanol for 5 minutes. Wells were stained 543 with crystal violet and plaque images quantified by ImageJ using the ColonyArea plugin (50). 544
HFF cMYC response assay and quantitation 545
Parasites used for C-myc assays were grown 48 hours with or without 1 μg/mL ATc and 546 syringe-lysed prior to infection of host cell coverslips. Coverslips of confluent HFF monolayers 547 pretreated for 24 hours with FBS-free media were infected and fixed 19 hours post infection. 548
IFAs for human C-myc, HA and DAPI were performed as described above. Representative plaque assay is shown on the left. Results were quantitated based on percent 761 cell monolayer cleared by parasite (cleared area) and the average biological and experimental 762 triplicates are shown in graph (n=3, ±SD, p<0.0001 unpaired t test). 763 Figure 5 . Phenotype of GRA44 knockdown can be complemented. To establish a direct 764 connection between the lack of GRA44 and the phenotype observed, we established a 765 complemented strain by adding an exogenous copy of wild type GRA44 to the TATi-766 or with (+) ATc. Average percent cell monolayer cleared for biological and experimental 784 triplicates is shown by bar graph (n = 3 ±SD, **** p<0.0001 One-way ANOVA followed by 785 Tukey). 786 Cultures were stained for host cMYC (red), DAPI to detect DNA and nuclei (blue), and HA to 798 detect GRA44 (green). Arrows point at vacuoles with more than 2 parasites. B. Graph 799 represents average quantified nuclear signal from cMYC antibody staining across biological 800 and experimental triplicates. Arbitrary unites (AU) were used in comparing nuclear cMYC 801 signal intensity. (n= 3, ****p<0.0001 One-way ANOVA followed by Tukey). 802 803 804 805 TGGT1_316250  GRA45  TGGT1_204340  GRA54  TGGT1_254470  MYR1  TGGT1_319340  GRA52  TGGT1_279100  MAF1a  TGGT1_251540  GRA9  TGGT1_203600  GRA50  TGGT1_304955 serine/threonine specific protein phosphatase (PPM11C) TGGT1_315610
ID number Product description
hypothetical protein TGGT1_203290 GRA34 TGGT1_270320
protein phosphatase 2C domain-containing protein (PPM3C) TGGT1_258870
hypothetical protein TGGT1_311720 chaperonin protein BiP  TGGT1_226240  putative bud site selection protein  TGGT1_216770  hypothetical protein  TGGT1_220950  MAF1b  TGGT1_270240  MAG1  TGGT1_200360  hypothetical protein  TGGT1_290700  Gra25  TGGT1_258458  hypothetical protein  TGGT1_262050  rhoptry kinase family protein ROP39  TGGT1_410360  MAF1 copy  TGGT1_247440  GRA33  TGGT1_229480  putative calcium binding protein precursor  TGGT1_208830  GRA16  TGGT1_410370 MAF1 copy Table 1 . Putative GRA44 interactors identified by IP. Criteria used were Saint Score (SP) of 806 >0.8, and not ribosomal protein (TGGT1_309820, TGGT1_207840, TGGT1_266070, 807 TGGT1_248480). Highlighted proteins have a predicted signal peptide based on SignalP 808 analysis. Proteins are listed based on SAINT score, total peptides and fold change over 809 controls (table S2) . A.
-ATc +ATc cMyc Overlay: phase, cMyc, DAPI, HA
